APA (7th ed.) Citation

Sato, K., Hikita, H., Shigekawa, M., Soma, K., Yamauchi, R., Sung, J., . . . Takehara, T. (2024). The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis. Scientific Reports, 14(1), 1. https://doi.org/10.1038/s41598-024-62498-x

Chicago Style (17th ed.) Citation

Sato, Katsuhiko, et al. "The Serum Tenascin C Level Is a Marker of Metabolic Disorder-related Inflammation Affecting Pancreatic Cancer Prognosis." Scientific Reports 14, no. 1 (2024): 1. https://doi.org/10.1038/s41598-024-62498-x.

MLA (9th ed.) Citation

Sato, Katsuhiko, et al. "The Serum Tenascin C Level Is a Marker of Metabolic Disorder-related Inflammation Affecting Pancreatic Cancer Prognosis." Scientific Reports, vol. 14, no. 1, 2024, p. 1, https://doi.org/10.1038/s41598-024-62498-x.